Results 21 to 30 of about 10,333 (209)
Sleeping Sickness at the Crossroads
Tropical Medicine and Infectious Disease, 2020 Human African trypanosomiasis (HAT; sleeping sickness) is a disease with truly historic dimensions [...]
Christian Burri
doaj +1 more source
Therapeutic Strategies against Leishmania and Trypanosoma
Pathogens, 2023 Human African trypanosomiasis (also known as sleeping sickness, with Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense as etiological agents), American trypanosomiasis (also known as Chagas disease, with Trypanosoma cruzi as the etiological
André L. S. Santos +5 more
doaj +1 more source
Human African trypanosomiasis in travellers to Kenya [PDF]
Eurosurveillance, 2012 In this issue, two cases are described of human African trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense. They occurred recently in European tourists returning from Masai Mara area, Kenya, to Germany and Belgium, respectively [1,2]. These are, to our knowledge, the first two HAT cases described in travellers to Kenya in the last 12 years ...
Gobbi F, Bisoffi Z
openaire +5 more sources
Tropical Medicine and Health, 2020 Background Tsetse flies are the cyclical vectors of both human and animal diseases. Kenya’s commitment to eradicate tsetse and trypanosomiasis dates to the 1980s through various control approaches which were spearheaded by the African Union.
Ferdinard Adungo +3 more
doaj +1 more source
A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense. [PDF]
PLoS Neglected Tropical Diseases, 2016 Humans are protected against infection from most African trypanosomes by lipoprotein complexes present in serum that contain the trypanolytic pore-forming protein, Apolipoprotein L1 (APOL1).
Anneli Cooper +7 more
doaj +1 more source
Generation of neuroinflammation in human African trypanosomiasis [PDF]
Neurology Neuroimmunology & Neuroinflammation, 2019 Human African trypanosomiasis (HAT) is caused by infection due to protozoan parasites of the Trypanosoma genus and is a major fatal disease throughout sub-Saharan Africa. After an early hemolymphatic stage in which the peripheral tissues are infected, the parasites enter the CNS causing a constellation of neurologic features.
Rodgers, Jean +2 more
openaire +3 more sources
Case of Nigeria-Acquired Human African Trypanosomiasis in United Kingdom, 2016
Emerging Infectious Diseases, 2017 Human African trypanosomiasis has not been reported in Nigeria since 2012. Nevertheless, limitations of current surveillance programs mean that undetected infections may persist.
Akish Luintel +6 more
doaj +1 more source
Immunophenotypic lymphocyte profiles in human african trypanosomiasis. [PDF]
PLoS ONE, 2009 Human African trypanosomiasis (HAT) is a deadly vector-born disease caused by an extracellular parasite, the trypanosome. Little is known about the cellular immune responses elicited by this parasite in humans.
Caroline Boda +9 more
doaj +1 more source
Human African trypanosomiasis control: Achievements and challenges. [PDF]
PLoS Neglected Tropical Diseases, 2017 Sleeping sickness, also known as human African trypanosomiasis (HAT), is a neglected disease that impacts 70 million people living in 1.55 million km2 in sub-Saharan Africa.
Serap Aksoy +4 more
doaj +1 more source
A doença de Chagas: repercussões de uma descoberta científica brasileira em Portugal, 1909-1924
Ler História, 2022 Currently, Chagas disease, or human American trypanosomiasis, affects around 900 people in Portugal, mostly Brazilian immigrants, the main foreign population residing in the country.
Ewerton Luiz Figueiredo Moura da Silva
doaj +1 more source